Zealand Pharma

316.20 DKK

+3.50%

Less than 1K followers

ZEAL

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

+3.50 %
+6.11 %
-20.83 %
-32.20 %
-33.72 %
-34.68 %
+42.30 %
+60.43 %
+297.74 %

Zealand Pharma operates in biotechnology. Special focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest operations are in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Søborg, Denmark.

Read more
Market cap
22.62B DKK
Turnover
63.31M DKK
Revenue
9.21B
EBIT %
75.52 %
P/E
3.45
Dividend yield-%
-
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7.5
2026

Interim report Q1'26

26.5
2026

Extraordinary general meeting '26

13.8
2026

Interim report Q2'26

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
HCA Morgenbørs 09/03 - Et store fald på futures fronten, oliepriser har krydset 100 og øget nervøsitet omkring finansiering af AI udbygningen
Video by

HCA Morgenbørs 09/03 - Et store fald på futures fronten, oliepriser har krydset 100 og øget nervøsitet omkring finansiering af AI udbygningen

I dagens Morgenbørs ser vi ind i et store fald på futures fronten, oliepriser har krydset 100 og øget nervøsitet omkring finansiering af AI udbygningen. Herhjemme, fokus på bl.a. Novo, Zealand, høreapparatsproducenterne.